It’s not as if you don’t already have too much to think about, but here’s one more side effect of treatment you need to address: bone loss.
Premature menopause, triggered by chemo, can cause a sudden drop in estrogen levels and weaken bones. Vitamin D deficiency, a secondary cause of bone loss, affected 65 percent of women in a recent study of breast cancer patients. And now aromatase inhibitors, a common treatment which interferes with the body’s ability to produce the hormone estrogen, has been shown to decrease bone mineral density and increase the risk of fractures in postmenopausal women. But researchers have found that for many women, there are effective therapies.
Source: Health Insider
No comments:
Post a Comment